ASCO Program Improves Oncology Practice Performance

This article originally appeared here.
Share this content:
Program Linked to Medical Oncology Practice Improvement
Program Linked to Medical Oncology Practice Improvement

(HealthDay News) -- For medical oncology practices in the United States, participation in the American Society of Clinical Oncology's Quality Oncology Practice Initiative (QOPI) correlates with improvements in measured performance, especially with regard to newly introduced clinical information, according to research published online March 11 in the Journal of Clinical Oncology.

Michael N. Neuss, M.D., of the Vanderbilt University Medical Center in Nashville, Tenn., and colleagues surveyed 156 medical oncology practices in the United States to determine whether QOPI scores have improved over time and, if so, which factors were associated with improvement.

From 2006 to 2010, average adherence to quality indicators for the medical oncology practices surveyed improved from 0.71 to 0.85. Many measures did not change over time. However, the greatest improvement was seen in the introduction of new clinical information. The least improvement was seen in the management of symptoms/toxicity. Overall adherence to quality care standards was highest in breast cancer and lowest in non-small cell lung cancer.

"In summary, QOPI provides a structure for oncology practice group self-examination that has been widely adopted and shows practice improvement over time," the authors write. "The absence of improvement in which wide performance gaps remain in some specific areas demonstrates the opportunity to cross the quality chasm. The development of tools and incentives to inspire the improvement are obvious and important next steps."

Two authors disclose payments or honoraria received in connection with the study.

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs